Effect of angiotensin II antagonism on the regression of kidney disease in the rat  by Remuzzi, Andrea et al.
Kidney International, Vol. 62 (2002), pp. 885–894
Effect of angiotensin II antagonism on the regression
of kidney disease in the rat
ANDREA REMUZZI, ELENA GAGLIARDINI, CHIARA DONADONI, ANNA FASSI, FABIO SANGALLI,
MARIA SERENA LEPRE, GIUSEPPE REMUZZI, and ARIELA BENIGNI
Mario Negri Institute for Pharmacological Research, and Unit of Nephrology and Dialysis, Azienda Ospedaliera,
Ospedali Riuniti di Bergamo, Bergamo, Italy
Effect of angiotensin II antagonism on the regression of kidney loss in experimental and human proteinuric chronic renal
disease in the rat. diseases [1] to the extent that angiotensin-converting
Background. Normalization of proteinuria and even regres- enzyme (ACE) inhibitors and Ang II receptor antago-sion of glomerulosclerosis seem to occur in progressive renal
nists are now recommended in clinical settings. Experi-disease upon blockade of the renin-angiotensin system. Here
we quantified the effect of a combination of an angiotensin mental studies on the renoprotective effects of these
converting enzyme (ACE) inhibitor and an angiotensin II (Ang classes of drugs usually have been performed to demon-
II) receptor antagonist on renal function and structure in spon- strate prevention of proteinuria and kidney injury rather
taneous overt nephropathy in male Munich Wistar Fromter
than to examine remission of the disease or regression(MWF) rats.
of already established structural changes. While progres-Methods. Three groups of MWF rats were used: group 1
was studied at 25 weeks to provide baseline renal function and sive deterioration of renal function was previously con-
structure; group 2 was followed until 40 weeks of age; group sidered an inexorable process, occasional observations
3 was treated with lisinopril (40 mg/L) and valsartan (180 mg/L) in humans and subsequent, more systematic studies inin drinking water from 25 to 40 weeks. A group of untreated
both humans and experimental animals have indicatedWistar rats (group 4, 40 weeks) was used as the control. At
the end of the study renal hemodynamics, kidney tissue mor- collectively that remission of proteinuria, improvement
phology, accumulation of type III collagen and evaluation of of renal function and even regression of renal structural
interstitial inflammatory cells were performed. injury may actually occur. Repeated renal biopsy 10 yearsResults. MWF rats spontaneously developed hypertension,
after pancreas transplantation showed a trend for renalproteinuria, glomerulosclerosis, interstitial volume expansion
and protein cast accumulation. Combined treatment completely lesions to regress including less mesangial expansion, more
reversed protein excretion and ameliorated renal plasma flow open capillaries and less interstitial fibrosis [2]. These
and the glomerular ultrafiltration coefficient. The combined clinical observations have potential pitfalls, but moretherapy was effective in halting progressive glomerulosclerosis,
rigorous experiments done in animals were confirmatory.particularly in glomeruli with mild sclerotic lesions, and re-
duced interstitial volume expansion. Type III collagen accumu- ACE inhibitor given late during the animal’s life, when
lation and protein cast also were reversed. Infiltrating cells animals were already heavily proteinuric, decreased blood
were massively present in the interstitium already at 25 weeks, pressure and proteinuria and stopped the disease fromand augmented at 40 weeks in untreated rats. Combined treat-
progressing in Munich Wistar Fromter (MWF) rats [3],ment reduced infiltrating cells to values comparable to normal
controls. which are genetically programmed to develop protein-
Conclusions. These data indicate that in animals with spon- uria and progressive renal damage with age, as docu-
taneous overt nephropathy, Ang II antagonism normalized pro- mented by a lower incidence of glomeruli affected byteinuria, eliminated inflammatory cell infiltration, and amelio-
sclerotic lesions and less interstitial injury than in un-rated glomerular and tubular structural changes.
treated controls. In a more recent study Ma and cowork-
ers found that sclerosis was remodeled in aging rats by
inhibiting the renin-angiotensin system with an Ang IIAntagonism of the biological actions of angiotensin II
(Ang II) effectively reduces the rate of renal function receptor antagonist given at high doses for six months
[4]. The effect was attributed to the modulation of corti-
cal cell turnover and inhibition of plasminogen activator-1Key words: glomerular filtration rate, ACE inhibition, proteinuria, ure-
mia, renoprotective drugs, progressive renal disease, hemodynamics. (PAI-1) expression. In humans, regression of chronic renal
disease was observed in the context of the Ramipril Effi-Received for publication August 1, 2001
cacy in Nephropathy (REIN) follow-up study [5]. Actu-and in revised form April 17, 2002
Accepted for publication April 19, 2002 ally, in patients with chronic nephropathy and high risk
of rapid progression to end-stage renal failure, an ACE 2002 by the International Society of Nephrology
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Fig. 1. The experimental design. Symbols
are: () proteinuria, systemic blood pressure;
() renal function, kidney morphology.
inhibitor reversed the tendency of the glomerular filtra- an Ang II receptor antagonist (valsartan, 180 mg/L in
the drinking water) from 25 to 40 weeks of age. Wistartion rate (GFR) to decline with time. Even more impor-
tantly, a treatment period of sufficient duration (36 animals (group 4, N  7), used as controls, were left
untreated until 40 weeks of age. Starting from week 25months) eliminated the need for dialysis in these patients.
These experimental and clinical observations open the of age, awake systolic blood pressure (SBP) and urinary
protein excretion rate were measured each five weeks,question to which extent Ang II antagonism effectively
induces regression of renal disease at functional and with methods previously described in detail [7]. All ani-
mals were maintained in a temperature-controlled roomstructural level.
The aim of the present study was to quantify the im- regulated with a 12/12 hour light/dark cycle, and had
free access to water and food (standard rat chow withprovement in functional and structural changes that de-
velop spontaneously in male MWF rats, in animals 20% in protein). At sacrifice, renal hemodynamic evalua-
tion and morphological analysis of kidney tissue weretreated with a combination of an ACE inhibitor and an
Ang II receptor antagonist, to block both generation and performed in all groups of animals.
biological activity of Ang II. To this purpose, male MWF
Renal hemodynamicsrats at the age of 25 weeks were used, when renal func-
tional and structural changes are already developed, and Total kidney GFR and renal plasma flow (RPF) were
determined, using inulin and p-aminohippuric acid (PAH)the effects of a 15 week therapy on proteinuria, renal
hemodynamics, and kidney structural changes were stud- clearance as described previously [7]. Briefly, after anes-
thesia, 1.6 mL/kg 0.9% NaCl containing inulin (5%) andied. We also characterized cellular components of kidney
tissue infiltrates. These observations were compared to PAH (0.2%) was infused through the femoral vein. A
sustained infusion of inulin and PAH solution was thenthose obtained in untreated MWF rats at 25 and 40 weeks
of age and in a group of untreated Wistar rats at 40 started at 1.5 mL/h and maintained throughout the dura-
tion of the experiment. Continuous blood pressure moni-weeks of age taken as normal controls.
toring was obtained by a polyethylene catheter inserted in
the femoral artery. After a 40 to 50 minute equilibration
METHODS
period, three timed clearance periods of approximately
Study design 30 minutes each were started by collecting urine samples
by bladder incannulation. Blood samples were obtainedTwenty-one male MWF rats from our colony [6] and
seven male Wistar rats (Charles River, Calco, Italy), at from the femoral artery at the midpoint of each clearance
period. Inulin and PAH concentrations in plasma andthe age of 25 weeks, were used in this study. MWF rats
were divided in three groups, according to the experi- urine samples were determined with colorimetric assays
as described previously [8].mental design graphically represented in Figure 1. Group
1 (N 7) was composed of MWF untreated rats studied
Morphological evaluationat 25 weeks of age. Animals of Group 2 (N  7) were
left untreated until 40 weeks of age. Animals of Group Kidney tissue was perfusion fixed at the end of renal
hemodynamic study, using 1.25% glutaraldehyde in 0.13 (N  7) were treated with a combination of an ACE
inhibitor (lisinopril 40 mg/L in the drinking water) and mol/L cacodylate buffer solution and post-fixation in Du-
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bosq-Brazil fluid. After paraffin embedding, sections complex (ABC) solution, and finally developed with di-
aminobenzidine. The sections were then counterstained3-m in thickness (Ultrotome V; LKB, Bromma, Swe-
den) were stained with Masson’s trichrome, hematoxylin with Harris hematoxylin (Biooptica, Milan, Italy). Nega-
tive control was obtained by omitting the primary anti-and eosin (H&E), and by the periodic acid-Schiff (PAS)
techniques, as previously described. The incidence and body on a second section present on all the slides. The
signal intensity was graded on a scale of 0 to 3 (0  noextension of glomerular and tubular structural lesions
were estimated with slight modifications of previously de- staining; 1  weak staining, 2  staining of moderate
intensity; 3  strong staining).scribed methods [6]. In detail, at least 100 glomeruli were
examined for each animal. Each glomerulus was scored
Evaluation of inflammatory and immune cell infiltratesaccording to the extension of sclerosis changes as follows:
0  absence of sclerosis; 1  sclerotic changes affecting Mouse monoclonal antibodies were used for the detec-
tion of the following antigens: (1) ED1 antigen presentless than 25% of glomerular tuft area; 2 and 3  lesions
affecting 25 to 50% and 50 to 75% of the tuft, and 4  in rat monocytes and macrophages (Chemicon); (2) CD4
cell surface glycoprotein, a 55 kD molecule expressedlesions exceeding 75% of the tuft. The average glomeru-
losclerosis index in each animal was then calculated by by helper T cells, thymocytes, and macrophages (W3/25;
Serotec, Oxford, UK); (3) rat CD8 cell surface glycopro-the weight-average of each class. All renal biopsies were
analyzed by the same examiner, who was unaware of tein expressed by T-suppressor/cytotoxic cells (OX8;
Pharmingen, Los Angeles, CA, USA); (4) rat MHC classthe nature of the experimental groups.
The density of cortical interstitial volume was deter- II antigen monomorphic determinant (OX6; Serotec);
and (5) an -like integrin subunit on rat dendritic cellsmined by computer based morphometric analysis. Tissue
sections were examined on a Zeiss light microscope (OX62; Serotec). All antigens were analyzed by indirect
immunofluorescence technique. As previously described,(Zeiss, Jena, Germany) connected to a video camera
(Panasonic; Matsushita Elect. Co., Osaka, Japan) and a the tissue fragments were frozen in liquid nitrogen [10].
computer-based image analysis system. For each kidney Tissue sections (3 m thick) were cut using a Mikrom
section, 20 systematically selected fields in the renal cor- 500 O cryostat (Walldorf, Germany) and fixed with ace-
tex were digitized. The density of the interstitial volume tone. The sections were blocked with phosphate-buf-
was measured by point counting using a 10 10 orthogo- fered saline (PBS)/1% bovine serum albumin (BSA),
nal grid digitally overlayed on the image (NIH Image incubated overnight at 4C with the primary antibody
v. 1.82; NIH, Bethesda, MD, USA) with an expected (ED1, 14 g/mL; W3/25, 40 m/mL; OX8, 1:100; OX6,
probable error less than 5% of the mean volume density 5 g/mL; OX62, 10 g/mL), washed with PBS, and then
[9]. The incidence of tubular casts was quantified by incubated with Cy3-conjugated donkey anti-mouse IgG
computation of average number of casts per microscopic antibodies (affinity-purified, absorbed with rat IgG, 5
field on systematically sampled images of renal cortex g/mL in PBS; Jackson ImmunoResearch, West Grove,
and medulla. In each animal the entire transversal sec- PA, USA) for one hour at room temperature. For each
tion of the kidney was used and counts of protein cast marker, the number of cells was counted in at least 10
were related to the extension of cortex and medulla by randomly selected high-power microscope fields (400)
appropriate point counting using the previously de- for each animal.
scribed orthogonal grid. The number of casts/field was
Statistical analysisthen calculated separately for cortex and medulla.
Data are expressed as mean  standard deviation
Evaluation of type III collagen deposition (SD) or median and range as specified in the text. Data
Type III collagen accumulation was detected by immu- were analyzed by the analysis of variance (ANOVA)
noperoxidase using a polyclonal rabbit anti-rat type III and differences between groups were established by the
collagen antibody (Chemicon, Temecula, CA, USA). Student t test with Bonferroni correction for multiple
Dubosq-Brazil fixed, paraffin embedded kidney sections comparisons. Non-parametric data (morphometric scores)
were deparaffinized, rehydrated and incubated for 30 were analyzed by the Kruskal-Wallis test and the Ryan’s
minutes with 0.3% H2O2 in methanol to quench endoge- procedure for multiple comparisons. A level of P  0.05
nous peroxidase. Tissues were treated with proteinase-K was considered statistically significant.
(20 g/mL; Sigma-Aldrich, Milan, Italy) for 10 minutes
at 37C, followed by microwave and citrate buffer incu-
RESULTSbations to increase the reactivity of antibody to antigen.
At the end of the study, body weight was significantlyPrimary antibody was then added overnight at 4C (di-
lower in MWF animals than in controls, and was notluted 1:100), followed by the secondary antibody (biotin-
significantly affected by the combined administration ofylated goat-anti-rabbit IgG diluted 1:200; Vector Labora-
tories, Burlingame, CA, USA), avidin-biotin peroxidase lisinopril and valsartan in MWF rats (Table 1). A similar
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Table 1. Systemic and kidney functional parameters, at whole organ and single nephron level, in MWF and in Wistar rats
MWF 25 weeks MWF 40 weeks MWF 	 Lis/Val 40 weeks Wistar 40 weeks
BW g 41518 43616 42917 72783a
KW g 1.880.25 2.040.11 1.770.20 3.190.49a
AP mm Hg 12015 12918 9919b 1128
GFR mL/min/100g BW 0.710.12 0.310.08c 0.320.04c 0.570.20
RPF mL/min/100g BW 2.090.31 1.020.34c 1.650.35b 1.770.12
FF % 3510 349 215d 309
SNGFR nL/min 11519 5516e 525e 6516e
Qa nL/min 34244 19592e 27460 22935e
Kf nL/min/mm Hg 5.630.93 2.660.53e 4.030.65f 4.691.93

P mm Hg (assumed) 45 45 35 40
Data are expressed as mean  SD. Abbreviations are: BW, body weight; KW, kidney weight; AP, mean arterial pressure during hemodynamic study; GFR,
glomerular filtration rate; RPF, renal plasma flow; FF, filtration fraction; SN, single nephron; Qa, afferent arteriolar plasma flow; Kf, glomerular ultrafiltration
coefficient; 
P, mean glomerular transmembrane pressure difference.
a P  0.01 vs. MWF at same age
b P  0.05 vs. MWF 40 weeks
c P  0.01 vs. MWF 25 weeks and vs. Wistar 40 weeks
d P  0.05 vs. MWF 25 weeks and vs. MWF 40 weeks
e P  0.05 vs. MWF 25 weeks
f P  0.01 vs. MWF 40 weeks
trend was observed for kidney weight. As shown in Fig- reduced in untreated MWF rats at 40 weeks of age.
Combined treatment did not prevent the age relatedure 2, untreated MWF rats developed moderate hyper-
tension as early as 25 weeks. SBP values remained sig- decrease in total kidney GFR. Renal plasma flow (RPF)
was comparable in untreated rats at 25 weeks and innificantly elevated in untreated MWF rats above control
values recorded in Wistar rats. Combined therapy had Wistar controls, while it was significantly reduced in
MWF rats at 40 weeks. At variance to GFR, RPF de-a remarkable antihypertensive effect as the animals
maintained SBP at values comparable to normal con- crease with age in MFW rats was significantly prevented
by treatment. As a result, filtration fraction was elevatedtrols. Urinary protein excretion was significantly higher
at 25 weeks in untreated MWF rats than in Wistar con- above Wistar rats in untreated MWF animals, both at
25 and 40 weeks, and was significantly reduced by thetrols (Fig. 2), and progressively increased with age.
Chronic inhibition of the renin-angiotensin system not combination therapy.
On the basis of previous determinations of the numberonly prevented, but also reversed progressively urinary
protein excretion during the observation period, reach- of nephrons in these two animal strains [7], we calculated
the mean glomerular filtration rate (SNGFR) and affer-ing values comparable to those of normal controls by
the end of the observation period, with complete remis- ent arteriole plasma flow (Qa) at the level of a single
glomerulus. Briefly, a total of 28,000 nephrons in malesion of proteinuria (Fig. 2). Animals studied at 25 weeks
of age showed values of SBP (153 6 mm Hg) compara- MWF rats and 54,000 nephrons in Wistar rats were as-
sumed. It was calculated that non-sclerotic glomerulible to those measured in untreated and in treated MWF
rats followed until 40 weeks (153  11 and 152  3 contributed completely to GFR, while sclerosed glomer-
uli contributed only to the extent of the tuft volume notmm Hg, respectively). Similarly, urinary protein excre-
tion was comparable in animals sacrificed at 25 weeks affected by sclerosis. Thus, we defined the contribution
to GFR as 75%, 50%, 25% and 0%, respectively, for(165  21 mg/24 h) and in the other two MWF groups
evaluated at the same age (186 46 and 196 30 mg/24 h, glomeruli of the four sclerosis scores from 1 to 4 as
determined by morphological analysis. We then calcu-respectively).
lated corresponding average SNGFR and Qa values of
Renal function evaluation the entire nephron population in each animal. Group
average values are reported in Table 1. According toThe results of kidney hemodynamic studies are re-
ported in Table 1. Mean arterial pressure recorded dur- these calculations, in MWF rats at 25 weeks of age mean
SNGFR and Qa exceeded the corresponding values ofing anesthesia was only numerically higher in untreated
MWF rats at 25 weeks than in Wistar controls and MWF the Wistar group, suggesting glomerular hyperfiltration
and hyperperfusion in this strain was the result of arats at 40 weeks. Combined treatment reduced mean
arterial pressure that was maintained significantly lower reduced number of nephrons. With age these animals
developed important reductions in SNGFR and Qa thatin these animals than in MWF rats of same age. Glomeru-
lar filtration rate per unit of body weight (GFR) was not were not completely prevented by the combined therapy.
Actually, treated animals showed no changes in SNGFRsignificantly different in untreated MWF rats at 25 weeks
as compared to Wistar controls, while was significantly at 40 weeks compared to untreated MWF, and there was
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were then assumed for each group, in line with previously
published measurements at earlier age, with and without
ACE inhibition/Ang II receptor antagonist treatment
[11]. Assumed values of
P and corresponding calculated
Kf values are reported in Table 1. The mean Kf value in
MWF rats at 25 weeks of age was numerically higher
than corresponding values estimated for normal Wistar
rats, but the difference did not reach statistical signifi-
cance. Kf importantly decreased with age in untreated
MWF rats, as it was significantly lower in untreated MWF
rats at 40 weeks in comparison to rats of the same strain
at 25 weeks. Of interest, combined therapy favorably
affected the age-related decrease in Kf that, by the end
of the treatment period, was still comparable to the basal
value at 25 weeks. These results indicate that the lower
perfusion pressure, at arterial and glomerular levels, was
balanced by elevation in Kf to preserve GFR.
Morphological evaluation
Quantitative assessments of the structural changes of
kidney tissue in untreated and treated MWF rats and in
normal controls are reported in Table 2 and in Figure
3. Morphological evaluation of the kidney at light micros-
copy in untreated animals at 25 weeks showed segmental
areas of glomerulosclerosis affecting 19% of glomeruli
on average, enlargement of tubular interstitial volume
over controls and abundant presence of protein casts
either in cortex and medulla. The extent of glomerulo-
sclerosis in individual glomerular sections also was as-
sessed and glomeruli were grouped into four ranks of
surface extent of glomerular sclerosis from 1 to 4. Results
are shown in Figure 3. At 25 weeks most of glomeruli
were in the first sclerosis rank with only 1  2% of
glomeruli affected by most severe sclerotic changes. Re-
Fig. 2. Systolic blood pressure (SBP) and urinary protein excretion nal structural abnormalities progressively worsened in
rate in MWF and in Wistar rats followed from 25 to 40 weeks of
untreated animals at 40 weeks. Glomerulosclerosis sig-age. A group of MWF rat (MWF 40W 	 Lis/Val) was treated with a
combination of lisinopril and valsartan from the 25 to 40 weeks of age. nificantly increased over corresponding values of MWF
Data are presented as mean  SD. Symbols are: () MWF 40 weeks; rats at 25 weeks overall affecting 26% glomeruli. The per-
() Wistar 40 weeks; ( ) MWF 40 weeks, treated with Lis and Val;
centage of glomeruli with mild sclerotic damage (score 1)*P  0.01 vs. MWF 40 week age group.
worsened with age in these animals. Combination ther-
apy completely prevented the worsening of glomerular
structural changes and even induced a statistically sig-
partial prevention of the decline in Qa with age (Table nificant reduction of the incidence of glomeruli with scle-
1). To estimate more directly the effect of treatment on rotic changes affecting less than 25% of the tuft area
the determinants of glomerular filtration, we calculated leaving unaffected the percentage of glomeruli calcu-
the value of glomerular ultrafiltration coefficient (Kf) in lated for the remnant categories of damage. Interstitial
individual animals on the basis of SNGFR and Qa, of volume significantly increased in MWF rats over controls
measured plasma protein concentrations (Ca), and on already at 25 weeks and further rose at 40 weeks. Lisino-
the assumed mean value of glomerular transmembrane pril and valsartan remarkably prevented interstitial vol-
pressure difference (
P). Actually we did not directly ume expansion with age to values significantly lower
measure the glomerular hydraulic pressure because of than in MWF rats at 40 weeks. Significant regression of
our previous difficulties in performing micropuncture interstitial volume was observed also in these animals as
studies in the MWF rat at ages exceeding 25 weeks (A. compared to MWF rats at 25 weeks. Accumulation of
Remuzzi, unpublished observation), likely because of proteinaceous material in cortex and medulla was al-
ready observed in MWF rats at 25 weeks and worsenedthe advanced stage of renal structural changes. 
P values
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Table 2. Structural changes of kidney tissue in MWF and in Wistar rats
MWF 25 weeks MWF 40 weeks MWF 	 Lis/Val 40 weeks Wistar 40 weeks
Glomeruli affected by GS % 19 (11–31) 26 (22–39)a 12 (6–24)b 1 (0–3)c
GS Index 0.33 (0.25–0.44) 0.49 (0.33–0.78)a 0.27 (0.08–0.56)b 0.01 (0.0–0.03)c
Interstitial volume % 21.51.3 25.31.8a 18.42.5d 13.30.7c
Protein casts in cortex N/field 0.26 (0.17–0.55) 0.49 (0.11–0.72) 0.06 (0.03–0.22)d 0.02 (0.0–0.04)e
Protein casts in medulla N/field 1.50 (0.40–2.30) 3.64 (1.67–5.71)f 1.01 (0.40–1.48)g 0.08 (0.00–0.12)e
Collagen III accumulation score 2.1 (1.5–3.0) 2.4 (2.0–3.0) 1.3 (1.0–2.0)e 1 (1.0–1.0)d
Data are expressed as median (range) or mean  SD.
Abbreviations are: GS, glomerulosclerosis, 25 weeks, at 25 weeks of age; 40 weeks, at 40 weeks of age; Lis/Val, combination of lisinopril and valsartan treatment.
a P  0.05 vs. MWF 25 week group
b P  0.05 vs. MWF 40 week group
c P  0.01 vs. all MWF groups
d P  0.05 vs. MWF 25 week and P  0.01 vs. MWF 40 week group
e P  0.01 vs. MWF 25 week and vs. MWF 40 week group
f P  0.01 vs. MWF 25 weeks
g P  0.01 vs. MWF 40 weeks
collagen accumulation in MWF rats, whose levels de-
creased from 25 to 40 weeks to scores comparable to
those of control Wistar rats (Fig. 4D). Collagen staining
was completely abrogated omitting the primary anti-
body, indicating staining specificity (Fig. 4E).
Evaluation of inflammatory cells
A detailed immunohistological evaluation of intersti-
tial inflammatory cells was undertaken to compare the
number of monocyte/macrophages, MHC II positive
cells, dendritic cells, and CD4	, CD8	 T cells in un-
treated or lisinopril and valsartan treated animals and
controls. Results are given in Figures 5 and 6. Focal
infiltrates in peritubular cortical interstitium of ED-1,
MHC II	, dendritic cells and CD4	, CD8	 lympho-
cytes were already observed in untreated MWF rats atFig. 3. Incidence of glomerulosclerosis (GS) in untreated MWF rats
at 25 ( ) and 40 weeks () of age, and in MWF treated with lisinopril 25 weeks with counts for monocytes/macrophages and
and valsartan ( ) from 25 to 40 weeks of age. Percentage of glomeruli
dendritic cells significantly increased with respect to con-affected by different degree of sclerosis was calculated according to the
score definition given in the text. Data are represented as mean  SD. trols. Accumulation of the infiltrating cells further aug-
*P  0.01 vs. MWF 40 week group and P  0.05 vs. MWF 25 week mented at 40 weeks in untreated MWF animals, reaching
group.
values significantly higher than those at 25 weeks and
controls for all the cell types. Blocking Ang II synthesis
and activity completely normalized parenchyma infil-
further with time. Combined treatment induced regres- trating cells and the numbers of inflammatory cells were
sion of protein cast accumulation to levels that in cortex comparable to those counted in normal control rats.
was not different from those of normal controls.
DISCUSSIONType III collagen deposition
Results of the present study show that treatment with aThe results on type III collagen accumulation that
combination of an ACE inhibitor and an Ang II receptorwas semiquantitatively evaluated in kidney samples are
antagonist fully eradicated proteinuria, improved glo-reported in Table 2 and in Figure 4. Positive staining of
merular ultrafiltration coefficient (Kf), and partially re-type III collagen was occasionally found in the intersti-
gressed the early glomerulosclerosis changes and tubulo-tium of control Wistar rats sacrificed at 40 weeks (Fig.
interstitial injury. There are few reports on the effects4C). A significant increase of collagen accumulation was
of chronic inhibition of renin-angiotensin system in aobserved in tubulointerstitium of MWF rats at 25 (Fig.
setting of overt chronic proteinuria on renal function4A, P  0.05) and 40 weeks (Fig. 4B, P  0.01) as
and structure [12–15]. In most of these studies the diseasecompared to controls. Differences in the tissue type III
was not severe enough, as judged by baseline proteinuria,collagen accumulation were not observed over time in
MWF rats. Combined treatment ameliorated type III nor was the dose of ACE inhibitor used high enough
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Fig. 4. Representative immunoperoxidase staining for type III collagen in the kidney of untreated MWF rats at 25 (A) and 40 (B) weeks, in
lisinopril and valsartan treated MWF (C ) and in Wistar rats (D). No specific signals were obtained omitting the primary antibody (E ). Original
magnification, 250. (Reproduction of this figure in color was made possible by the generous sponsorship of Novartis Pharma AG, Basel,
Switzerland.)
[16, 17] to draw definitive conclusions on the degree of angiotensin system on glomerulosclerosis and interstitial
expansion has been attributed to the lowered glomerularregression of renal functional and structural changes. In
the present study we chose to combine an ACE inhibitor pressure and to the unique effect of ACE inhibitors and
Ang II receptor antagonist to restore the size-selectiveand an Ang II receptor antagonist in order to maximize
the Ang II blockade. In addition, we quantified kidney dysfunction of the glomerular barrier [8, 18–20]. In addi-
tion to these general effects at the whole organ level,function and structure before and after treatment, and
obtained reference values in a normal rat strain. In pre- local conditions may be heterogeneous in glomerular
diseases, and glomeruli may be affected by different de-vious studies, the beneficial effect of inhibiting renin-
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Fig. 6. Evaluation of infiltrating CD4	 and CD8	 cells by immunohis-
tochemical analysis in untreated and lisinopril and valsartan treated
animals and controls. *P  0.01 vs. Wistar rats. P  0.01 vs. MWF
rats at 40 weeks.
Fig. 5. Immunohistochemical staining for (A) infiltrating monocytes/
macrophages, (B ) MHCII cells, and (C ) dendritic cells in untreated
and lisinopril and valsartan treated animals and controls. *P  0.01 vs. tional benefit to glomerular structure, reversing early but
Wistar rats. P  0.01 vs. MWF rats at 40 weeks. not advanced glomerular lesions [17]. The same benefi-
cial effect observed at glomerular level was documented
at tubular interstitial level. Ang II antagonist not only
halted progressive expansion of interstitial volume, butgree of sclerosis. Thus, inhibiting the renin-angiotensin
was able to reverse the tendency of interstitial volumeaxis has conceivably different effects at the single neph-
to increase with age.ron level, depending on the degree of glomerulosclerosis.
Among the factors associated with tissue injury in pro-Glomeruli with more advanced sclerosis may never re-
gressive renal disease, other than glomerular hyperten-gain function. Here, we observed that the incidence of
sion and proteinuria, are infiltrating mononuclear cells,glomeruli with mild sclerotic damage increased more
macrophages and T cells, which become activated andwith age in MWF rats than that of glomeruli with more
participate in parenchyma scarring by synthesizing andsevere glomerulosclerosis. Combined treatment halted
secreting fibrogenic cytokines, which may stimulate in-damage almost completely in each category of glomeruli
terstitial fibroblast proliferation and matrix accumula-studied, although glomeruli with early sclerotic lesions
tion. The key role of infiltrating cells in inducing intersti-were particularly responsive to the renin-angiotensin sys-
tial injury leading to further inflammation and fibrosistem blockade, as documented by the significant reduc-
has been documented extensively in the last few years.tion of the incidence of glomeruli with sclerotic changes
Evidence supports the hypothesis that interstitial in-affecting less than 25% of the tuft area. This is consistent
flammatory cells initially recruited in response to injurywith previous data showing that ACE inhibitors, at doses
exceeding the antihypertensive doses, imparted an addi- subsequently contribute to interstitial fibrosis. Further-
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more, therapeutic interventions that dampen the intersti- the glomerular ultrafiltration pressure difference is likely
depressed as compared to the awake state.tial inflammatory response preserve renal function from
Translating these considerations into humans allowsprogressive deterioration. In line with the concept of a
a more precise interpretation of remission/regressionrole of interstitial damage in renal disease progression
findings in the Lewis study and REIN follow-up study.are human data showing that the impairment of GFR
Actually, the ACE inhibitor treatment in these patientsin progressive renal diseases correlated better with the
was effective in reducing proteinuria or slowing the de-extent of tubulointerstitial injury than with the degree
cline in GFR despite the expected reduction in glomeru-of glomerular structural damage. In this context, it is not
lar hydraulic pressure. These changes may be regardedknown whether, and to what extent, the inflammatory
as signs of improved glomerular filtration capacity andreaction that follows hemodynamic derangement and
preservation of tubular function and structure. The im-tubular protein trafficking can be reversed. Pharmaco-
proved Kf derived from this animal study probably islogical inhibition of Ang II synthesis and biological activ-
implicated in humans also. Whether this ameliorationity remarkably ameliorated renal interstitial abnormali-
implies remodeling of glomerular capillary lumen withties, reduced accumulation of protein casts to levels that,
the opening of obliterated loops needs formal demon-in the cortex, were even lower than those of untreated
stration.MWF at a younger age. Combined therapy also induced
In conclusion, our data indicate that antagonism ofevident signs of regression of collagen III accumulation.
Ang II synthesis and activity induced a complete normal-Consistently, the number of inflammatory cells infiltrat-
ization of proteinuria and some degree of regression ofing the interstitium was lowered by the treatment to
kidney structural changes that previously developed invalues comparable to controls. All of these findings show
these rats with age. Further investigation is needed toa remarkable effect of the treatment on established inter-
document the extent to which the regression of func-stitial lesions and cell infiltration, which should prelude
tional and structural lesions may occur in human progres-an equally important protection from the destructive
sive kidney diseases, using drugs that antagonize theconsequences of macrophage and T cell infiltration. That
biological actions of Ang II.the kidney can be remodeled and regain function to a
certain degree, depending of course on the severity of the
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